Beresniak A - Search Results

1

Helicobacter pylori "Test-and-Treat" strategy with urea breath test: A cost-effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain-Results of the Hp-Breath initiative.

Beresniak A, Malfertheiner P, Franceschi F, Liebaert F, Salhi H, Gisbert JP. Beresniak A, et al. Helicobacter. 2020 Aug;25(4):e12693. doi: 10.1111/hel.12693. Epub 2020 Apr 13. Helicobacter. 2020. PMID: 32285569

2

Cost-effectiveness modelling of use of urea breath test for the management of Helicobacter pylori-related dyspepsia and peptic ulcer in the UK.

Pritchard DM, Bornschein J, Beales I, Beresniak A, Salhi H, Malfertheiner P. Pritchard DM, et al. Among authors: beresniak a. BMJ Open Gastroenterol. 2021 Jul;8(1):e000685. doi: 10.1136/bmjgast-2021-000685. BMJ Open Gastroenterol. 2021. PMID: 34244244 Free PMC article.

3

Modelling cost-effectiveness of biologic treatments based on disease activity scores for the management of rheumatoid arthritis in Spain.

Beresniak A, Ariza-Ariza R, Garcia-Llorente JF, Ramirez-Arellano A, Dupont D. Beresniak A, et al. Int J Inflam. 2011;2011:727634. doi: 10.4061/2011/727634. Epub 2011 Jun 28. Int J Inflam. 2011. PMID: 21785694 Free PMC article.

4

Assessing the cost-effectiveness of biologic agents for the management of moderate-to-severe rheumatoid arthritis in anti-TNF inadequate responders in Italy: a modelling approach.

Cimmino MA, Leardini G, Salaffi F, Intorcia M, Bellatreccia A, Dupont D, Beresniak A. Cimmino MA, et al. Among authors: beresniak a. Clin Exp Rheumatol. 2011 Jul-Aug;29(4):633-41. Epub 2011 Aug 31. Clin Exp Rheumatol. 2011. PMID: 21813056

5

Cost-effectiveness of mitral valve repair versus replacement by biologic or mechanical prosthesis.

Beresniak A, Sabatier B, Achouh P, Menasché P, Fabiani JN. Beresniak A, et al. Ann Thorac Surg. 2013 Jan;95(1):98-104. doi: 10.1016/j.athoracsur.2012.08.005. Epub 2012 Oct 11. Ann Thorac Surg. 2013. PMID: 23063201

6

Cost-effectiveness simulation model of biologic strategies for treating to target rheumatoid arthritis in Germany.

Beresniak A, Baerwald C, Zeidler H, Krüger K, Neubauer AS, Dupont D, Merkesdal S. Beresniak A, et al. Clin Exp Rheumatol. 2013 May-Jun;31(3):400-8. Epub 2013 Mar 4. Clin Exp Rheumatol. 2013. PMID: 23464803

7

Interest of modelling in rheumatoid arthritis.

Beresniak A, Dupont DM, Becker JC, Merkesdal S. Beresniak A, et al. Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S96-101. Epub 2012 Oct 18. Clin Exp Rheumatol. 2012. PMID: 23078913 Review.

8

Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease.

Beresniak A, Caruba T, Sabatier B, Juillière Y, Dubourg O, Danchin N. Beresniak A, et al. World J Cardiol. 2015 Oct 26;7(10):594-602. doi: 10.4330/wjc.v7.i10.594. World J Cardiol. 2015. PMID: 26516413 Free PMC article.

9

Direct cost-modeling of rheumatoid arthritis according to disease activity categories in France.

Beresniak A, Gossec L, Goupille P, Saraux A, Bamberger M, Bregman B, Dupont D. Beresniak A, et al. J Rheumatol. 2011 Mar;38(3):439-45. doi: 10.3899/jrheum.100589. Epub 2010 Dec 1. J Rheumatol. 2011. PMID: 21123324

10

Cost-effectiveness of public health interventions against human influenza pandemics in France: a methodological contribution from the FLURESP European Commission project.

Beresniak A, Rizzo C, Oxford J, Goryński P, Pistol A, Fabiani M, Napoli C, Barral M, Niddam L, Bounekkar A, Bonnevay S, Lionis C, Gauci C, Bremond D. Beresniak A, et al. Eur J Public Health. 2020 Feb 1;30(1):43-49. doi: 10.1093/eurpub/ckz074. Eur J Public Health. 2020. PMID: 31056657

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters